XE5-11611-91228
4 vaccinations
2 coded responses
50 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 971 / OR
- Registered
- 2021-04-25
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3ZG-10773-14257
Child or adolescent in my care · Female · 2022-09-25
Timeline
-
2021-04-25
Registered in v-safe
-
2021-04-25
Dose 1 — Pfizer-BioNTech
- 2021-04-25
-
2021-04-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-09
-
2021-05-16
Dose 2 — Pfizer-BioNTech
- 2021-05-16
- 2021-05-16
-
2021-05-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-18
Survey response — days 1–6 daily, dose 2MedDRA: Brain fog, Disturbance in attention, Mental impairment — Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessFree text: Brain fog or trouble thinking/concentratingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-19
- 2021-05-20
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-30
- 2021-06-06
- 2021-06-13
- 2021-06-20
- 2021-06-27
- 2021-08-15
- 2021-11-14
-
2021-12-04
Dose 3 — Pfizer-BioNTech
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Fatigue or tiredness, NauseaAdult check-in
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-13
- 2021-12-18
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-03-05
- 2022-06-04
-
2022-09-22
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-12-22
-
2023-03-23
Survey response — 6 months, dose 4MedDRA: Cough, Headache, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-25 | Pfizer-BioNTech | |
| 2 | 2021-05-16 | Pfizer-BioNTech | |
| 3 | 2021-12-04 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | Flu |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Brain fog or trouble thinking/concentrating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Brain fog | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Mental impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release